Labiana Health (XMAD:LAB) EBIT : €-5.73 Mil (TTM As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health EBIT?

Labiana Health's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2022 was €-5.53 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was €-5.73 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Labiana Health's annualized ROC % for the quarter that ended in Dec. 2022 was -10.37%. Labiana Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -34.07%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Labiana Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -10.88%.

Labiana Health EBIT Historical Data

The historical data trend for Labiana Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health EBIT Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

EBIT

2.48

0.01

-5.73

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
EBIT	-	-	-0.20	-5.53

Competitive Comparison of Labiana Health's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Labiana Health's EV-to-EBIT falls into.

Labiana Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.73 Mil.

Labiana Health (XMAD:LAB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Labiana Health's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

	ROC % (Q: Dec. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2022 )	+	Invested Capital (Q: Dec. 2022 ))	/ count )
=	-5.05 * ( 1 - -13.48% )	/	( (57.898	+	52.676)	/ 2 )
=	-5.73074	/	55.287
=	-10.37 %

where

	Invested Capital		(Q: Jun. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	75.163	-	15.186	-	( 6.052	-	max(0, 37.337	-	39.416	+	6.052	))
=	57.898

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	60.779	-	14.411	-	( 2.544	-	max(0, 35.065	-	28.757	+	2.544	))
=	52.676

Note: The Operating Income data used here is two times the semi-annual (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Labiana Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2022		Q: Dec. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-11.068	/	( ( (20.264 + max(14.735, 0))	+	(20.636 + max(9.342, 0)) )	/	2 )
=	-11.068	/	( ( 34.999	+	29.978 )	/	2 )
=	-11.068	/	32.4885
=	-34.07 %

where Working Capital is:

	Working Capital		(Q: Jun. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.781	+	17.481	+	1.757)	-	(15.186	+	0	+	1.098)
=	14.735

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.778	+	13.833	+	1.788)	-	(14.411	+	0	+	0.646)
=	9.342

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Labiana Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2022 )
	=	-5.733	/	52.695
	=	-10.88 %

Labiana Health EBIT Related Terms

Thank you for viewing the detailed overview of Labiana Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.